Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000232818 | SCV000290275 | benign | Adams-Oliver syndrome 5 | 2024-01-18 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000428430 | SCV000535591 | likely benign | not specified | 2017-12-07 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Ambry Genetics | RCV001170712 | SCV000739353 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2016-01-21 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
CHEO Genetics Diagnostic Laboratory, |
RCV001170712 | SCV001333313 | benign | Familial thoracic aortic aneurysm and aortic dissection | 2018-10-23 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000232818 | SCV002555142 | benign | Adams-Oliver syndrome 5 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002270045 | SCV002555144 | benign | Aortic valve disease 1 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000428430 | SCV004803417 | benign | not specified | 2024-01-15 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001573043 | SCV004810484 | likely benign | not provided | 2024-03-01 | criteria provided, single submitter | clinical testing | NOTCH1: BP4, BP7 |
Laboratory of Diagnostic Genome Analysis, |
RCV001573043 | SCV001798339 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001573043 | SCV001807716 | likely benign | not provided | no assertion criteria provided | clinical testing |